UBS raised the firm’s price target on Ameren (AEE) to $114 from $113 and keeps a Buy rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AEE:
- Ameren’s Growth Prospects and Strategic Initiatives Justify Buy Rating
- Ameren price target lowered to $102 from $103 at Morgan Stanley
- Ameren Enters Forward Sale Agreements with Major Banks
- UnitedHealth, Wayfair downgraded: Wall Street’s top analyst calls
- Ameren price target raised to $112 from $108 at Wells Fargo